Peptide biotech MBX submits IPO plans, making a trio of post-Labor Day Nasdaq hopefuls
Indiana biotech startup MBX Biosciences filed for an initial public offering on Friday night.
It became the third clinical-stage drug developer …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
